GLOBEIMMUNE INC 4
4 · GLOBEIMMUNE INC · Filed Mar 21, 2016
Insider Transaction Report
Form 4
GLOBEIMMUNE INCGBIM
Torres S. Edward
Director
Transactions
- Sale
Common Stock
2016-03-17$1.67/sh−26,188$43,637→ 241,706 total(indirect: By LLC)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.60 to $1.84 per share, inclusive. The reporting person undertakes to provide to GlobeImmune, Inc., any security holder of GlobeImmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
- [F2]These shares are owned directly by Lilly Ventures Fund I, LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein.